Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Covera-HS Articles

STRONG DOLLAR WEAKENS US 1993 RESULTS

31 January 1994

IMPACT OF SWEDISH REFERENCE PRICING

10 January 1994

KNOLL SIGNS DEAL WITH SIBERIAN COs

10 January 1994

IVAX AND KNOLL REACH AGREEMENT

10 January 1994

IVAX SEES NICHEPRODUCTS AS ITS FUTURE

20 December 1993

BASF TO PRODUCE IN SIBERIA

20 December 1993

US 3rd QUARTER RESULTS - SOME IMPROVEMENT

6 December 1993

NEW CANCER THERAPIES MOVE INTO THE CLINIC

4 October 1993

BULGARIA - SUCCESS FOR NIHFI LTD

13 September 1993

KNOLL AHEAD IN 1992 BUT 1st QTR FALLS

3 May 1993

AMERICAN HOME HAS CONFIDENCE FOR 1993

12 April 1993

PFIZER DISREGARDS WSJ "SCARE STORY"

15 February 1993

RECORD RESULTS FROM US PHARMA MAJORS

1 February 1993

FDA APPROVES 26 NEWDRUGS IN 1992

25 January 1993

IVAX ALMOST "FULLY FLEDGED DRUG CO"

21 December 1992

ASTRA IS CHEM INSIGHT'S STAR PERFORMER

14 December 1992

US CHEMICAL/PHARMA COS' POOR PERFORMANCE

9 November 1992

GERMAN HEALTH REFORMS DEPRESS BASF

9 November 1992

IVAX NOTIFICATION

2 November 1992

FOCUS ON IVAX PRODUCT PIPELINE

12 October 1992

IVAX MARKETING

7 September 1992

GOOD GROWTH FOR US COMPANIESCONTINUES FOR US COs

3 August 1992

HYPERTENSION OPTIMAL TREATMENT STUDY

22 June 1992

STRONG EXPANSION AT KNOLL IN 1991

13 April 1992

Showing 101-124 of 124 articles

Go to beginningPrevious
  • 1
  • 2
NextGo to end
  • Hot Topics
  • Most Read
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS